These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25662333)

  • 1. Crucial role for the VWF A1 domain in binding to type IV collagen.
    Flood VH; Schlauderaff AC; Haberichter SL; Slobodianuk TL; Jacobi PM; Bellissimo DB; Christopherson PA; Friedman KD; Gill JC; Hoffmann RG; Montgomery RR;
    Blood; 2015 Apr; 125(14):2297-304. PubMed ID: 25662333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modeling of ligand and mutation sites of the type A domains of human von Willebrand factor and their relevance to von Willebrand's disease.
    Jenkins PV; Pasi KJ; Perkins SJ
    Blood; 1998 Mar; 91(6):2032-44. PubMed ID: 9490688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective collagen binding and increased bleeding in a murine model of von Willebrand disease affecting collagen IV binding.
    Slobodianuk TL; Kochelek C; Foeckler J; Kalloway S; Weiler H; Flood VH
    J Thromb Haemost; 2019 Jan; 17(1):63-71. PubMed ID: 30565388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction of von Willebrand factor-A1 domain with collagen: mutation G1324S (type 2M von Willebrand disease) impairs the conformational change in A1 domain induced by collagen.
    Morales LD; Martin C; Cruz MA
    J Thromb Haemost; 2006 Feb; 4(2):417-25. PubMed ID: 16420575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetics of type 2 von Willebrand disease.
    Fressinaud E; Mazurier C; Meyer D
    Int J Hematol; 2002 Jan; 75(1):9-18. PubMed ID: 11843298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new mutation, S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease.
    Stepanian A; Ribba AS; Lavergne JM; Fressinaud E; Juhan-Vague I; Mazurier C; Girma JP; Meyer D
    Br J Haematol; 2003 Feb; 120(4):643-51. PubMed ID: 12588351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetics of von Willebrand disease.
    Mazurier C; Ribba AS; Gaucher C; Meyer D
    Ann Genet; 1998; 41(1):34-43. PubMed ID: 9599650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N1421K mutation in the glycoprotein Ib binding domain impairs ristocetin- and botrocetin-mediated binding of von Willebrand factor to platelets.
    Lanke E; Kristoffersson AC; Isaksson C; Holmberg L; Lethagen S
    Eur J Haematol; 2008 Nov; 81(5):384-90. PubMed ID: 18637125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.
    Gadisseur A; van der Planken M; Schroyens W; Berneman Z; Michiels JJ
    Acta Haematol; 2009; 121(2-3):145-53. PubMed ID: 19506361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purified A2 domain of von Willebrand factor binds to the active conformation of von Willebrand factor and blocks the interaction with platelet glycoprotein Ibalpha.
    Martin C; Morales LD; Cruz MA
    J Thromb Haemost; 2007 Jul; 5(7):1363-70. PubMed ID: 17389010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and laboratory phenotype variability in type 2M von Willebrand disease.
    Doruelo AL; Haberichter SL; Christopherson PA; Boggio LN; Gupta S; Lentz SR; Shapiro AD; Montgomery RR; Flood VH
    J Thromb Haemost; 2017 Aug; 15(8):1559-1566. PubMed ID: 28544236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of von Willebrand disease.
    Mazurier C; Meyer D
    Baillieres Clin Haematol; 1996 Jun; 9(2):229-41. PubMed ID: 8800502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
    Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A discontinuous autoinhibitory module masks the A1 domain of von Willebrand factor.
    Deng W; Wang Y; Druzak SA; Healey JF; Syed AK; Lollar P; Li R
    J Thromb Haemost; 2017 Sep; 15(9):1867-1877. PubMed ID: 28692141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A3 domain is essential for interaction of von Willebrand factor with collagen type III.
    Lankhof H; van Hoeij M; Schiphorst ME; Bracke M; Wu YP; Ijsseldijk MJ; Vink T; de Groot PG; Sixma JJ
    Thromb Haemost; 1996 Jun; 75(6):950-8. PubMed ID: 8822592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical von Willebrand factor A1 domain residues influence type VI collagen binding.
    Flood VH; Gill JC; Christopherson PA; Bellissimo DB; Friedman KD; Haberichter SL; Lentz SR; Montgomery RR
    J Thromb Haemost; 2012 Jul; 10(7):1417-24. PubMed ID: 22507569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a myeloma patient with a life-threatening hemorrhagic diathesis: presence of a lambda dimer protein inhibiting shear-induced platelet aggregation by binding to the A1 domain of von Willebrand factor.
    Shinagawa A; Kojima H; Berndt MC; Kaneko S; Suzukawa K; Hasegawa Y; Shigeta O; Nagasawa T
    Thromb Haemost; 2005 May; 93(5):889-96. PubMed ID: 15886805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermodynamic stabilization of von Willebrand factor A1 domain induces protein loss of function.
    Sandoval-Pérez A; Mejía-Restrepo V; Aponte-Santamaría C
    Proteins; 2022 Dec; 90(12):2058-2066. PubMed ID: 35833249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of W1745C and S1783A: 2 novel mutations causing defective collagen binding in the A3 domain of von Willebrand factor.
    Riddell AF; Gomez K; Millar CM; Mellars G; Gill S; Brown SA; Sutherland M; Laffan MA; McKinnon TA
    Blood; 2009 Oct; 114(16):3489-96. PubMed ID: 19687512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. von Willebrand factor A1 domain can adequately substitute for A3 domain in recruitment of flowing platelets to collagen.
    Bonnefoy A; Romijn RA; Vandervoort PA; VAN Rompaey I; Vermylen J; Hoylaerts MF
    J Thromb Haemost; 2006 Oct; 4(10):2151-61. PubMed ID: 16805860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.